CJC-1295 (With DAC) 2mg (Lyophilized Powder) For Research Use Only
CJC-1295 with DAC (Drug Affinity Complex) is a long-acting GHRH analogue that covalently binds to serum albumin via the DAC technology, significantly extending its half-life to approximately 6–8 days. It has been studied for its ability to produce sustained elevation of GH and IGF-1 levels.
Research suggests CJC-1295 with DAC may promote prolonged anabolic signaling, consistent IGF-1 elevation, improved nitrogen retention, and fat oxidation compared to shorter-acting GHRH analogues.
Product Details:
Peptide: CJC-1295 With DAC (Long-Acting GHRH Analogue)
Purity: >98%
Form: Lyophilized powder
Quantity: 2mg per vial
Storage: Store at -4°F (-20°C). After reconstitution, refrigerate at 36°F (2–8°C) and use within 30 days.
Grade: For research purposes only. Not for human consumption, therapeutic, or diagnostic use.
Potential Research Applications:
Long-acting GHRH receptor stimulation studies
Sustained IGF-1 and GH elevation research
DAC albumin-binding technology models
Prolonged anabolic and lipolytic signaling investigations
For laboratory research use only. This product is not intended to diagnose, treat, cure, or prevent any disease.
